iBio, Inc. (IBIO) Depreciation USD 2012 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
iBio, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • iBio, Inc. Depreciation for the quarter ending September 30, 2023 was $165 K, a 39.1% decline year-over-year.
  • iBio, Inc. annual Depreciation for 2023 was $674 K, a 70.4% decline from 2022.
  • iBio, Inc. annual Depreciation for 2022 was $2.28 M, a 382% increase from 2021.
  • iBio, Inc. annual Depreciation for 2021 was $472 K, a 67.4% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $165 K -$106 K -39.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $2.24 M $271 K -$35 K -11.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.28 M $743 K +$601 K +423% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-27
Q1 2022 $1.67 M $709 K +$590 K +496% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.08 M $517 K +$403 K +354% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $681 K $306 K +$209 K +215% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $472 K $142 K +$67 K +89.3% Apr 1, 2021 Jun 30, 2021 10-K 2022-10-11
Q1 2021 $405 K $119 K +$49 K +70% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $356 K $114 K +$43 K +60.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $313 K $97 K +$31 K +47% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $282 K $75 K -$287 K -79.3% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 $569 K $70 K -$271 K -79.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $840 K $71 K -$293 K -80.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $1.13 M $66 K -$294 K -81.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.43 M $362 K +$341 M Apr 1, 2019 Jun 30, 2019 10-K 2020-10-13
Q1 2019 -$339 M $341 K -$341 M -99.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.41 M $364 K +$23 K +6.75% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $1.39 M $360 K +$22 K +6.51% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.37 M -$340 M -$341 M -100487% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-26
Q1 2018 $342 M $341 M* +$341 M +101087% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.36 M $341 K +$15 K +4.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $1.34 M $338 K +$14 K +4.32% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1.33 M $339 K +$25 K +7.96% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-18
Q1 2017 $1.3 M $337 K +$76 K +29.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $1.23 M $326 K +$325 K +32500% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 $900 K $324 K +$323 K +32300% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $577 K $314 K Apr 1, 2016 Jun 30, 2016 10-K 2017-09-15
Q1 2016 $261 K +$250 K +2273% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1 K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-21
Q3 2015 $1 K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-18
Q1 2015 $11 K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-23
Q3 2014 $1 K $0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q3 2013 $1 K +$1 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.